Sagimet Biosciences Series A Statistics
NASDAQ: SGMTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
8.88+0.12 (+1.37%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Sagimet Biosciences Series A by the numbers
Sagimet Biosciences Series A has a market capitalization of $629.7 million based on 70.34M shares outstanding. With trailing EPS of $-1.27, Sagimet Biosciences Series A is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.5% below its 50-day average and 23.3% above its 200-day average.
Average daily trading volume is 1.24M shares, or about $11.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SGMT valuation vs. peer median
| Metric | SGMT | Peer median | Difference |
|---|---|---|---|
| Market cap | $629.67M | $631.80M | -0% |
| Avg. volume | 1.24M | 1.26M | -1% |
Peer median across 8 companies: IRWD, CLYM, SLN, FTH, AQST, ABUS, ZVRA, NVCT.
Valuation
- Market cap
- $629.67M
- EPS (TTM)
- $-1.27
- Shares outstanding
- 70.34M
Price and trading
- Previous close
- 8.76
- Open
- 8.65
- Day range
- 8.60 – 8.97
- 52-week range
- 4.50 – 11.45
- 52-week change
- +20.98%
- Beta
- —
- Volume
- 625.52K
- Average volume
- 1.24M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2026
Additional statistics
- Market Cap
- 629.67M
- Forward Pe
- -6.83
- Eps
- -1.27
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 11.45
- Week52 Low
- 4.50
- Avg Volume
- 1.24M
- Shares Outstanding
- 70.34M
- Ma50
- 9.81
- Ma200
- 7.20
- Earnings Date
- Aug 11, 2026
- Pct From52w High
- -22.44%
- Pct From52w Low
- 97.33%